Cluster Health & Mission Cancer Brokerage Event

28 Sept 2026 | Brussels, Belgium

TUBITAK Marmara Research Center

R&D Institution

mam.tubitak.gov.tr/en/Kocaeli, Türkiye
8 profile visits

About

TUBITAK Marmara Research Center (TUBITAK MRC) is a multidisciplinary applied research and technology development centre of the Scientific and Technological Research Council of Türkiye (TÜBİTAK), with extensive experience in national and international R&D programmes and collaborative research.

Within its Climate and Life Sciences activities, the Biotechnology Research Group brings together multidisciplinary expertise in pharmaceutical technologies, molecular oncology, vaccine technologies, biomaterials, cell and molecular biology, immunology, bioinformatics and genetic engineering.

In the health and cancer research field, TÜBİTAK MAM has capabilities in the discovery and development of recombinant antibodies, monoclonal antibodies, scFvs and peptides, molecular target identification and validation, cancer biology, protein engineering, recombinant expression and purification, 2D/3D cell-based models, bioactivity and efficacy assessment, and development of innovative biopharmaceutical and targeted therapeutic approaches.

TÜBİTAK MAM is interested in contributing to Horizon Europe Cluster Health and EU Mission on Cancer consortia through complementary expertise in target validation, therapeutic antibody and peptide discovery, molecular oncology, biotechnology and translational research.

Social media

Representatives

Chief Senior Researcher

TUBITAK Marmara Research Center

Marketplace (1)

  • Project cooperation

    Antibody/scFv Discovery & Functional Validation of Novel Cancer Targets

    TUBITAK MRC offers expertise in cancer target validation, phage-display antibody/scFv and peptide discovery, recombinant antibody engineering and cell-based functional assessment for Horizon Europe Cancer Mission consortia.

    • Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
    Author

    Chief Senior Researcher at TUBITAK Marmara Research Center

    Kocaeli, Türkiye